Aromasin 25mg is a targeted hormonal therapy, classified as a steroidal aromatase inactivator, designed for postmenopausal women with estrogen-receptor-positive early or advanced breast cancer.
By binding irreversibly to the aromatase enzyme, Aromasin permanently deactivates it, reducing estrogen production that fuels certain cancer cells.
- Adjuvant Therapy: Reduces cancer recurrence risk after initial tamoxifen treatment.
- Advanced Cancer Management: Treats advanced breast cancer in postmenopausal women whose disease has progressed following prior anti-estrogen therapy.
Important Usage & Safety Information: This is a prescription medication, with a typical dose of one 25mg tablet taken orally once daily, after a meal.



Reviews
There are no reviews yet.